In oral cancer, elevated NLRP3 and IL-1β expression frequently correlate with tumor progression, largely driven by mitochondrial dysfunction, impaired autophagy, and alterations in the tumor-associated microbiota [74]. Here, NLRP3 is linked to lip and oral cavity carcinoma.